Prof Rajiv  Khanna

Prof Rajiv Khanna

Prof Rajiv Khanna obtained his doctorate degree from India & undertook his post-doctoral training at the University of Adelaide & (QIMR), Brisbane Australia. At QIMR Berghofer Medical Research Institute, Prof Khanna has been researching immunotherapy & has had a major breakthrough in treating the aggressive brain cancer, Glioblastoma Multiforme (GBM). He also holds a Senior Principal Research Fellowship from NH&MRC Australia. His research group have obtained a deeper understanding of the mechanisms by which an immune response to human herpes viruses associated diseases may be generated, augmented and applied to control these diseases. Prof. Khanna has developed novel immune-based therapeutic strategies for the treatment of patients with herpesvirus-associated complications & is lead investigator on five clinical trials. He has published more than 150 scientific papers in leading journals & holds numerous international patents on EBV and human cytomegalovirus.